Publicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (5)

2022

  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Blood, Vol. 140, Núm. 11, pp. 1200-1228

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2017

  1. MRD detection in multiple myeloma: Comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods

    Blood Advances, Vol. 1, Núm. 12, pp. 728-732

2016

  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    The Lancet Oncology, Vol. 17, Núm. 8, pp. e328-e346

2001

  1. Diagnostic performance of the urinary bladder carcinoma antigen elisa test and multiparametric dna/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma

    Cancer, Vol. 92, Núm. 11, pp. 2811-2819